Arsenal’s Bukayo Saka should be available to face Real Madrid in the Champions League, according to the latest news. The 23-year-old has been out of action since December 21 with a thigh injury ...

Arsenal could reap the rewards of shelving their interest in Newcastle forward Alexander Isak and signing Viktor Gyokeres instead. Both players have been linked with potential moves to the ...

All Picatinny Arsenal employees must return to work in person today amid I-80 woes in Wharton Posted: March 31, 2025 | Last updated: March 31, 2025 With the closure of I-80 severely impacting ...

Already, 5,000 tickets have been sold for Arsenal’s Women’s Champions League ... the strain that we've had on the squad but the medical team and performance team are doing an incredible ...

Arsenal have identified another European forward as a transfer target for the summer should they miss out on signing Alexander Isak, according to a report. The Gunners seem set to come up short in ...

Chicago Med season 10, episode 16 saw Goodwin and Frost each facing a demon of their past while also offering up an update on Ripley's suspension. CHICAGO MED -- "Poster Child" Episode 1016 -- ...

Article continues below Arsenal star Riccardo Calafiori went down with a nasty-looking injury towards the end of Italy's Nations League match against Germany, while Nottingham Forest's Chris Wood ...

Delhi Chief Minister Rekha Gupta allocated Rs 12,893 crore for healthcare in the 2025-26 budget, focusing on schemes like Ayushman Bharat, adding 16,186 hospital beds, and creating two medical ...

The Gunners have been at Emirates Stadium since 2006 and want to make upgrades to their north London home. Renovations have taken place in recent years, including the installation of new artwork ...

Arsenal laid their Women’s Champions League credentials out on the crisp Emirates Stadium pitch, a remarkable 3-0 victory ensuring their passage to the semi-finals. This was arguably the Gunners’ ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...